Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
N Engl J Med. 2016 May 5;374(18):1711-22. doi: 10.1056/NEJMoa1514204. Epub 2016 Apr 4.
N Engl J Med. 2016.
PMID: 27043165
Free article.
Clinical Trial.
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer.
Ojo D, Wu Y, Bane A, Tang D.
Ojo D, et al.
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):735-745. doi: 10.1016/j.bbadis.2017.12.018. Epub 2017 Dec 14.
Biochim Biophys Acta Mol Basis Dis. 2018.
PMID: 29248549
Free article.
Item in Clipboard
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.
Yin DE, et al.
Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.
Pediatrics. 2014.
PMID: 25266426
Free PMC article.
Clinical Trial.
Item in Clipboard
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team.
Harrison L, et al.
J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.
J Acquir Immune Defic Syndr. 2015.
PMID: 26322666
Free PMC article.
Clinical Trial.
Item in Clipboard
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
PENPACT-1 (PENTA 9/PACTG 390) Study Team; Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS.
PENPACT-1 (PENTA 9/PACTG 390) Study Team, et al.
Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31.
Lancet Infect Dis. 2011.
PMID: 21288774
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite